ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity.
about
Evaluation of Transient Elastography, Acoustic Radiation Force Impulse Imaging (ARFI), and Enhanced Liver Function (ELF) Score for Detection of Fibrosis in Morbidly Obese Patients.Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.Deletion of Wntless in myeloid cells exacerbates liver fibrosis and the ductular reaction in chronic liver injury.Multiplex Serum Protein Analysis Identifies Novel Biomarkers of Advanced Fibrosis in Patients with Chronic Liver Disease with the Potential to Improve Diagnostic Accuracy of Established BiomarkersEnhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting.Non-invasive fibrosis score for hepatitis delta.Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science.Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C.Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B.Association of fetuin B with markers of liver fibrosis in nonalcoholic fatty liver disease.Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease.Non-invasive evaluation of liver fibrosis: More well-validated tests available for patient management.Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysisFibrosis Staging Using Direct Serum Biomarkers is Influenced by Hepatitis Activity Grading in Hepatitis C Virus InfectionA Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At-Risk Populations in Primary Care
P2860
Q30398914-A4B595CD-38BC-4642-8287-DB03CDCF10C2Q33639969-CAC72693-1A42-4302-A12D-174BCD1E2416Q36163662-0EB101EC-1BEA-4A9B-ACE2-B4769827D985Q36197398-FB6EF97D-EABE-4669-B0FC-7EAA394DC17CQ38598029-8743BD2C-F484-46F6-A087-7CBC68C8AA7DQ40610178-DCF221FD-C935-438B-8331-E12F46CC2DC9Q45070782-41AC809C-064A-4CC1-B724-71D7A8B6765EQ46507190-525CF4CB-EE08-4FFB-BFA7-0BDF2F9954C0Q47630903-9333618C-EDEC-41AD-B256-D28D388A6C93Q47797020-82527D00-042C-4D14-A191-A39C13E3E424Q52902850-5B59EEC2-4073-48F0-86B6-62755CF91901Q53635973-02089140-1D0C-4791-898A-27EDD068F290Q56343202-D41BABA9-B3C4-4B83-8B33-463064B1B80AQ58749745-7E80DBD7-52C2-4189-8A59-87B58BBC8CEDQ58799831-D1001D90-D613-4EE4-B7BE-3A3BC00D4D91
P2860
ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
ELF score ≥9.8 indicates advan ...... sis and histological activity.
@en
ELF score ≥9.8 indicates advan ...... sis and histological activity.
@nl
type
label
ELF score ≥9.8 indicates advan ...... sis and histological activity.
@en
ELF score ≥9.8 indicates advan ...... sis and histological activity.
@nl
prefLabel
ELF score ≥9.8 indicates advan ...... sis and histological activity.
@en
ELF score ≥9.8 indicates advan ...... sis and histological activity.
@nl
P2093
P2860
P50
P356
P1433
P1476
ELF score ≥9.8 indicates advan ...... sis and histological activity.
@en
P2093
Gregory C Miller
Kevin J Fagan
Kihoon Choi
Leigh U Horsfall
Linda M Fletcher
Michelle Melino
Peter O'Rourke
Sharmin Nusrat
P2860
P304
P356
10.1111/LIV.12760
P577
2015-01-20T00:00:00Z